[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342735-105":59,"doc-detail-342735-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","foxp3-a-player-of-immunogenetic-architecture-in-lung-cancer","FOXP3: A Player of Immunogenetic Architecture in Lung Cancer","","The transcription factor forkhead box protein 3 (FOXP3) plays a central role in the immune system through regulatory T cells (Tregs), where it supports immune homeostasis and self-tolerance. Although FOXP3 was long considered Treg-specific, evidence shows it is also present across diverse benign tumors and carcinomas. This review consolidates findings on FOXP3 in lung cancer, examining its prognostic value, tumor-infiltrating FOXP3-positive lymphocytes, localization within tumor microenvironments, and implications for FOXP3-targeted therapy in a disease driving cancer mortality.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/foxp3-a-player-of-immunogenetic-architecture-in-lung-cancer/342735/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/foxp3-a-player-of-immunogenetic-architecture-in-lung-cancer/342735.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the role of FOXP3 in regulatory T cells (Tregs)?","Question",{"text":112,"@type":113},"FOXP3 is a transcription factor that is crucial for the development, function, and stability of Tregs. These cells suppress or downregulate the induction of effector T cells to maintain immune tolerance and homeostasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is FOXP3 related to lung cancer prognosis?",{"text":117,"@type":113},"Most reported data link FOXP3 with an unfavorable prognosis in lung cancer. However, some studies suggest an opposite function, so the relationship depends on context such as FOXP3 localization and tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"What aspects does the review cover regarding FOXP3 in lung cancer and therapy?",{"text":121,"@type":113},"The review discusses tumor FOXP3 expression, FOXP3-positive tumor-infiltrating lymphocytes, FOXP3 in tumor microenvironments, and the potential for therapies targeting FOXP3.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342735,1791180868,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review  \nFOXP3: A Player of Immunogenetic Architecture in Lung Cancer  \nIwona Ziółkowska-Suchanek *,† and Magdalena Z˙urawek †  \nCitation: Ziółkowska-Suchanek, I.; Z˙ urawek, M. FOXP3: A Player of Immunogenetic Architecture in Lung Cancer. Genes 2024, 15, 493. [https://](https://)[ ](https://)[doi.org/10.3390/genes15040493](doi.org/10.3390/genes15040493)  \nAcademic Editor: Daniel J. Weisenberger  \nReceived: 13 March 2024  \nRevised: 5 April 2024  \nAccepted: 12 April 2024  \nPublished: 15 April 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nInstitute of Human Genetics, Polish Academy of Sciences, Strzeszy ´nska 32, 60-479 Pozna ´n, Poland; [magdalena.zurawek@igcz.poznan.pl](magdalena.zurawek@igcz.poznan.pl)  \n* Correspondence: [iwona.ziolkowska@igcz.poznan.pl](iwona.ziolkowska@igcz.poznan.pl); Tel.: +48-61-6579219; Fax: +48-61-823323 † These authors contributed equally to this work.  \nAbstract: The transcription factor forkhead box protein 3 (FOXP3) is considered to be a prominent component of the immune system expressed in regulatory T cells (Tregs) . Tregs are immunosuppressive cells that regulate immune homeostasis and self-tolerance. FOXP3 was originally thought to be a Tregs-specific molecule, but recent studies have pinpointed that FOXP3 is expressed in a diversity of benign tumors and carcinomas. The vast majority of the data have shown that FOXP3 is correlated with an unfavorable prognosis, although there are some reports indicating the opposite function of this molecule. Here, we review recent progress in understanding the FOXP3 role in the immunogenetic architecture of lung cancer, which is the leading cause of cancer-related death. We discuss the prognostic significance of tumor FOXP3 expression, tumor-infiltrating FOXP3-lymphocytes, tumor FOXP3 in tumor microenvironments and the potential of FOXP3-targeted therapy.  \nKeywords: FOXP3; regulatory T cells; FOXP3 expression; tumor-infiltrating FOXP3-lymphocytes; tumor microenvironment; non-small cell lung cancer  \n1. Introduction  \nRegulatory T cells were initially discovered over two decades ago by Sakaguchi et al. in a distinct model of murine autoimmunity [1] . In 2001, human Tregs were identified in the thymus and peripheral blood of healthy individuals [2] . However, they are preferentially called regulatory cells instead of suppressor T cells; their primary and the most important function is to suppress or downregulate the induction of effector T cells. Treg cells are able to control the cell fate of self-reactive T cells and determine long-term tolerance. In humans and mice, Treg cells are characterized by the high expression of the IL-2 receptor alpha chain (IL-2Rα and CD25) and the expression of the transcription factor FOXP3, which is crucial for their development, function and stability [3] . Inactivating mutations in FOXP3 lead to severe autoimmunity with a scurfy phenotype in mice and Immunodysregulation Polyendocrinopathy Enteropathy X-linked (IPEX) syndrome in humans, which is manifested by immune dysregulation, polyendocrinopathy and enteropathy [4,5] . Moreover, the ablation of conditional FOXP3 allele Treg cells results in the generation of effector T cells, which cause inflammatory tissue lesions [6] . On the contrary, enhancing the expression of endogenous FOXP3 results in the potent regulatory function of CD4+ T cells [7] . Therefore, stable FOXP3 expression in mature Treg cells is essential for maintaining the transcriptional and functional program established during Treg development.  \nFOXP3 has been found to express abnormally in lung squamous cell carcinoma and lung adenocarcinoma, suggesting that this gene plays an oncogene role [8]","cbCaibQu9hf5WM1h","https://ap.wps.com/l/cbCaibQu9hf5WM1h","pdf",2298512,14,"English","# Introduction\n# Lung Cancer Epidemiology","[{\"question\":\"What is the role of FOXP3 in regulatory T cells (Tregs)?\",\"answer\":\"FOXP3 is a transcription factor that is crucial for the development, function, and stability of Tregs. These cells suppress or downregulate the induction of effector T cells to maintain immune tolerance and homeostasis.\"},{\"question\":\"How is FOXP3 related to lung cancer prognosis?\",\"answer\":\"Most reported data link FOXP3 with an unfavorable prognosis in lung cancer. However, some studies suggest an opposite function, so the relationship depends on context such as FOXP3 localization and tumor microenvironment.\"},{\"question\":\"What aspects does the review cover regarding FOXP3 in lung cancer and therapy?\",\"answer\":\"The review discusses tumor FOXP3 expression, FOXP3-positive tumor-infiltrating lymphocytes, FOXP3 in tumor microenvironments, and the potential for therapies targeting FOXP3.\"}]","FOXP3: A Player of Immunogenetic Architecture in Lung Cancer | PDF",1790047951,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7be8fa5c9681483a658d2ca7256b81d4.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b390cbae7e14a5ebfe1204f2c73cd800.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcd0eebff3fa59cbd26eb8514030b243.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b75107b73b7088f08718da9e72c4189.webp",980,1385]